111 related articles for article (PubMed ID: 8295830)
21. 131I therapy of toxic and non-toxic goiters.
Beckers C
Q J Nucl Med; 1999 Dec; 43(4):291-6. PubMed ID: 10731779
[TBL] [Abstract][Full Text] [Related]
22. [Radiobiologic basis for using 131I to treat patients with thyroid cancer].
Suwiński R; Gawkowska-Suwińska M
Wiad Lek; 2001; 54 Suppl 1():266-77. PubMed ID: 12182035
[TBL] [Abstract][Full Text] [Related]
23. Outpatient therapeutic 131I for thyroid cancer.
Panzegrau B; Gordon L; Goudy GH
J Nucl Med Technol; 2005 Mar; 33(1):28-30. PubMed ID: 15731017
[TBL] [Abstract][Full Text] [Related]
24. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75.
Coover LR; Silberstein EB; Kuhn PJ; Graves MW
J Nucl Med; 2000 Nov; 41(11):1868-75. PubMed ID: 11079497
[TBL] [Abstract][Full Text] [Related]
26. 131I exhalation by patients undergoing therapy of thyroid diseases.
Gründel M; Kopka B; Schulz R
Radiat Prot Dosimetry; 2008; 129(4):435-8. PubMed ID: 17993652
[TBL] [Abstract][Full Text] [Related]
27. Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice.
Biermann M; Pixberg MK; Dörr U; Dietlein M; Schlemmer H; Grimm J; Zajic T; Nestle U; Ladner S; Sepehr-Rezai S; Rosenbaum S; Puskás C; Fostitsch P; Heinecke A; Schuck A; Willich N; Schmid KW; Dralle H; Schober O;
Nuklearmedizin; 2005; 44(6):229-34, 236-7. PubMed ID: 16400382
[TBL] [Abstract][Full Text] [Related]
28. Procedure guideline for therapy of thyroid disease with (131)iodine.
Meier DA; Brill DR; Becker DV; Clarke SE; Silberstein EB; Royal HD; Balon HR;
J Nucl Med; 2002 Jun; 43(6):856-61. PubMed ID: 12050333
[No Abstract] [Full Text] [Related]
29. [Radioiodine therapy of differentiated thyroid cancer. Recommendations of the Therapy Study Group of the German Society of Nuclear Medicine].
Georgi P; Emrich D; Heidenreich P; Moser E; Reiners C; Schicha H
Nuklearmedizin; 1992 Aug; 31(4):151-3. PubMed ID: 1518724
[No Abstract] [Full Text] [Related]
30. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.
; Sisson JC; Freitas J; McDougall IR; Dauer LT; Hurley JR; Brierley JD; Edinboro CH; Rosenthal D; Thomas MJ; Wexler JA; Asamoah E; Avram AM; Milas M; Greenlee C
Thyroid; 2011 Apr; 21(4):335-46. PubMed ID: 21417738
[TBL] [Abstract][Full Text] [Related]
31. Monitoring of radioiodine in nuclear medical therapy.
Heinemann K; Vogt KJ; Friedrich W; Feinendegen LE
Strahlentherapie; 1983 Aug; 159(8):490-4. PubMed ID: 6623561
[TBL] [Abstract][Full Text] [Related]
32. Radionuclide therapy for thyroid disease.
McDougall IR
West J Med; 1992 Jul; 157(1):62. PubMed ID: 1413748
[No Abstract] [Full Text] [Related]
33. Current safety practices relating to I-131 administration for diseases of the thyroid: a survey of physicians and allied practitioners.
Greenlee C; Burmeister LA; Butler RS; Edinboro CH; Morrison SM; Milas M;
Thyroid; 2011 Feb; 21(2):151-60. PubMed ID: 21275765
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic strategies--nuclear medicine aspects].
Schicha H
Internist (Berl); 1988 Aug; 29(8):577-9. PubMed ID: 3053512
[No Abstract] [Full Text] [Related]
35. The EANM guideline on radioiodine therapy of benign thyroid disease.
Campennì A; Avram AM; Verburg FA; Iakovou I; Hänscheid H; de Keizer B; Petranović Ovčariček P; Giovanella L
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3324-3348. PubMed ID: 37395802
[TBL] [Abstract][Full Text] [Related]
36. 131I activity in urine to the sewer system due to thyroidal treatments.
Andrés C; Barquero R; Tortosa R; Nuñez C; del Castillo A; Vega-Carrillo HR; Alonso D
Health Phys; 2011 Aug; 101 Suppl 2():S110-5. PubMed ID: 21709491
[TBL] [Abstract][Full Text] [Related]
37. Commentary on Willegaignon et al.: outpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedure.
Marcus CS
Clin Nucl Med; 2011 Jun; 36(6):446. PubMed ID: 21552021
[No Abstract] [Full Text] [Related]
38. [Present status of unsealed radioisotope therapy in Japan based on the nation-wide questionnaire].
Oyamada H
Kaku Igaku; 1999 Feb; 36(2):71-81. PubMed ID: 10213974
[TBL] [Abstract][Full Text] [Related]
39. Radioactive iodine (131I) therapy for differentiated thyroid cancer in Japan: current issues with historical review and future perspective.
Higashi T; Kudo T; Kinuya S
Ann Nucl Med; 2012 Feb; 26(2):99-112. PubMed ID: 22081274
[TBL] [Abstract][Full Text] [Related]
40. Radionuclide therapy of the thyroid.
Clarke SE
Eur J Nucl Med; 1991; 18(12):984-91. PubMed ID: 1778212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
